Sellas Life Sciences Group Inc (NASDAQ:SLS)

2.37
Delayed Data
As of Sep 22
 -0.16 / -6.32%
Today’s Change
1.46
Today|||52-Week Range
10.89
-44.88%
Year-to-Date

Today’s Trading

Previous close2.53
Today’s open2.54
Day’s range2.37 - 2.61
Volume2,715
Average volume (3 months)219,538
Market cap$25.5M
Data as of 3:59pm ET, 09/22/2020

Growth & Valuation

Earnings growth (last year)+93.07%
Earnings growth (this year)+84.62%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratio0.5
Price/Sales--
Price/Book2.25

Competitors

 Today’s
change
Today’s
% change
SBPHSpring Bank Pharmace...-0.02-1.44%
ENTXEntera Bio Ltd-0.01-0.75%
ACORAcorda Therapeutics ...+0.02+3.17%
SNSSSunesis Pharmaceutic...-0.05-3.57%
Data as of 7:25pm ET, 09/22/2020

Financials

Next reporting dateNovember 12, 2020
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$19.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
New York, New York

Forecasts